Is cyclophosphamide self-defeating as an antitumor agents?
- PMID: 7400210
- PMCID: PMC12253885
- DOI: 10.1007/BF00411282
Is cyclophosphamide self-defeating as an antitumor agents?
Abstract
The study shows inhibition of the antitumor effect of cyclophosphamide (CPA) on mammary carcinomas growing in mice prior-immunized by intragastric inoculations of the tumor. Immunization with tumor cells through this route produces under certain conditions factors able to modulate the antigenic determinants on tumor cells. The possibility that the antigenicity of tumor cells might be an important factor in obtaining successful therapy with CPA is proposed.
References
-
- Bremberg, S.: The influence of host factors on cyclophosphamide treatment of Moloney virus-induced lymphomas. Eur. J. Cancer 6, 277–286 (1970) - PubMed
-
- Griswold, D.E., Heppner, G.H., Calabresi, P.: Selective suppression of humoral and cellular immunity with cytosine arabinoside. Cancer Res. 32, 298–301 (1972) - PubMed
-
- Heppner, G.H., Calabresi, P.: Suppression by cytosine arabinoside of serum blocking factors of cell-mediated immunity to syngeneic transplants of mouse mammary tumours. J. Nat. Cancer Inst. 48, 1161–1167 (1972) - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources